Literature DB >> 762243

C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.

T W Muhlfelder, J Niemetz, D Kreutzer, D Beebe, P A Ward, S I Rosenfeld.   

Abstract

Complement-activated human plasma causes generation of tissue factor in human leukocytes. This phenomenon appears to be related to the fifth component of complement (C5) as demonstrated by the use of C5 deficient-plasma and suppression of activity with antibody to C5. Isolation of the chemotactic factor from activated serum or trypsinization of purified C5 reproduces the phenomenon. These data provide evidence for a direct link between complement products and activation of the coagulation system. Because chemotactic peptides from C5 can be generated by a variety of enzymes, our findings suggest a relationship between complement, coagulation, and inflammation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762243      PMCID: PMC371929          DOI: 10.1172/JCI109269

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

Authors:  H Rothberger; T S Zimmerman; H L Spiegelberg; J H Vaughan
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

Review 2.  The pathology of renal homograft rejection. A review.

Authors:  D T Rowlands; G S Hill; C M Zmijewski
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

3.  Neutrophil aggregation and swelling induced by chemotactic agents.

Authors:  J T O'Flaherty; D L Kreutzer; P A Ward
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

4.  Further link between complement activation and blood coagulation.

Authors:  H Prydz; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

5.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

Review 6.  Coagulation and renal disease.

Authors:  P Kincaid-Smith
Journal:  Kidney Int       Date:  1972-10       Impact factor: 10.612

7.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

Authors:  U R Nilsson; R H Tomar; F B Taylor
Journal:  Immunochemistry       Date:  1972-07

8.  Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A.

Authors:  F R Rickles; J A Hardin; F A Pitlick; L W Hoyer; M E Conrad
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  Acute immunologic pulmonary alveolitis.

Authors:  K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  45 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 2.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

3.  Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

Authors:  R Lorenzet; J Niemetz; A J Marcus; M J Broekman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Antigen-induced monocyte procoagulant activity. Requirement for antigen presentation and histocompatibility leukocyte antigen-DR molecules.

Authors:  B S Schwartz
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 5.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 6.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits.

Authors:  P G Tipping; S R Holdsworth
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

8.  Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.

Authors:  Patricia Redecha; Nico van Rooijen; Donald Torry; Guillermina Girardi
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

9.  Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.

Authors:  S R Holdsworth; P G Tipping
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 10.  Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.

Authors:  G Girardi; N Mackman
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.